 mortal morbid patient placebo cardiac arrhythmia suppress trial background and method cardiac arrhythmia suppress trial hypothesi suppress ventricular ectopi myocardi infarct incid sudden death patient ventricular ectopi encainid moricizin activ drug placebo use encainid flecainid excess mortal mortal morbid random respect placebo result patient encainid placebo activ drug flecainid placebo activ drug mean follow-up month patient arrhythmia drug placebo nonarrhythm cardiac caus drug placebo noncardiac caus drug placebo cardiac death due myocardi infarct shock patient drug placebo congest heart failur drug placebo differ patient activ drug placebo incid nonleth ventricular tachycardia proarrhythmia syncop perman pacemak congest heart failur recurr myocardi infarct angina coronary-arteri bypass graft angioplasti conclus excess death due death due acut recurr myocardi infarct patient encainid flecainid nonleth event active-drug placebo group mechan excess mortal treatment encainid flecainid unknown